Literature DB >> 32810203

Efficacy of high-power and short-duration ablation in patients with atrial fibrillation: a prospective randomized controlled trial.

Dong Geum Shin1, Jinhee Ahn2, Sang-Jin Han3, Hong Euy Lim3.   

Abstract

AIMS: The formation of radiofrequency lesions depends on the power and duration of ablation, and the contact force (CF). Although high power (HP) creates continuous and transmural lesions, most centres still use 25-30 W for 30-40 s for safety reasons. We evaluated the clinical efficacy and safety of a HP and short-duration (HPSD) strategy for atrial fibrillation (AF) ablation. METHODS AND
RESULTS: One hundred and fifty patients [58.2 ± 10.0 years, 48% with paroxysmal AF (PAF)] scheduled for index AF ablation using a CF-sensing catheter were randomly assigned to three groups [30 W, 40 W, and 50 W at ablation sites of anterior, roof, and inferior segments of pulmonary vein (PV) antra and roof line between each upper PV]. In 25-30 W for ≤20 s was applied at posterior wall ablation site in all subjects. Compared with the 30 W and 40 W groups, procedure (P < 0.001) and ablation times (P < 0.001) were shorter and ablation number for PV isolation (P < 0.001) was smaller in the 50 W group. There were no significant differences in the CF and ablation index (AI) among the three groups. There were no significant differences in the procedure-related complication rates. During the 12-month follow-up, AF recurred in 24 (16%) patients with no significant difference among the groups (P = 0.769). In the multivariate analysis, non-PAF [hazard ratio (HR) 2.836, P = 0.045] and AI (HR 0.983, P = 0.001) were independent risk factors for AF recurrence.
CONCLUSION: Radiofrequency ablation with HPSD is a safe and effective strategy with reduced ablation number and shortened procedure time compared to conventional ablation. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2020. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; High power; Radiofrequency catheter ablation Randomized controlled trial

Mesh:

Year:  2020        PMID: 32810203     DOI: 10.1093/europace/euaa144

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  13 in total

1.  Meta-analysis comparing outcomes of high-power short-duration and low-power long-duration radiofrequency ablation for atrial fibrillation.

Authors:  Dibbendhu Khanra; Abdul Hamid; Saurabh Deshpande; Anindya Mukherjee; Sanjiv Petkar; Mohammad Saeed; Indranill Basu-Ray
Journal:  Anatol J Cardiol       Date:  2022-01       Impact factor: 1.596

2.  Higher than recommended lesion size index target values for pulmonary vein isolation result in better clinical outcomes in paroxysmal atrial fibrillation patients.

Authors:  Josip Katić; Ante Anić; Toni Brešković; Zrinka Jurišić
Journal:  J Interv Card Electrophysiol       Date:  2021-08-28       Impact factor: 1.759

Review 3.  Efficiency, Safety, and Efficacy of High-Power Short-Duration Radiofrequency Ablation in Patients with Atrial Fibrillation.

Authors:  Xuerong Sun; Jiang Lu; Jinxuan Lin; Tianjie Feng; Ni Suo; Lihui Zheng; Zhimin Liu; Gang Chen; Xiaohan Fan; Shu Zhang; Guodong Niu
Journal:  Cardiol Res Pract       Date:  2021-02-15       Impact factor: 1.866

4.  The efficacy of high-power short-duration radiofrequency for atrial fibrillation ablation: A protocol for systematic review and meta-analysis.

Authors:  Peng Zhang; Ling Ma; Fei Wang; Liang Shi
Journal:  Medicine (Baltimore)       Date:  2021-04-23       Impact factor: 1.817

5.  The superiority of high-power short-duration radiofrequency catheter ablation strategy for atrial fibrillation treatment: A systematic review and meta-analysis study.

Authors:  Yoga Waranugraha; Ardian Rizal; Achmad J Firdaus; Fransiska A Sihotang; Akita R Akbar; Defyna D Lestari; Muhammad Firdaus; Akhmad I Nurudinulloh
Journal:  J Arrhythm       Date:  2021-07-02

6.  Acute and long-term efficacy of ablation index-guided higher power shorter duration ablation in patients with atrial fibrillation: A prospective registry.

Authors:  So-Ryoung Lee; Hyoung-Seob Park; Eue-Keun Choi; Euijae Lee; Seil Oh
Journal:  J Arrhythm       Date:  2021-07-21

7.  Optimal Lesion Size Index for Pulmonary Vein Isolation in High-Power Radiofrequency Catheter Ablation of Atrial Fibrillation.

Authors:  Chi Cai; Jing Wang; Hong-Xia Niu; Jian-Min Chu; Wei Hua; Shu Zhang; Yan Yao
Journal:  Front Cardiovasc Med       Date:  2022-04-07

8.  High-power short-duration versus standard-power standard-duration settings for repeat atrial fibrillation ablation.

Authors:  Joey Junarta; Sean J Dikdan; Naman Upadhyay; Sairamya Bodempudi; Michael Y Shvili; Daniel R Frisch
Journal:  Heart Vessels       Date:  2021-11-30       Impact factor: 1.814

9.  Safety and Efficacy of High Power Shorter Duration Ablation Guided by Ablation Index or Lesion Size Index in Atrial Fibrillation Ablation: A Systematic Review and Meta-Analysis.

Authors:  Xing Liu; Chun Gui; Weiming Wen; Yan He; Weiran Dai; Guoqiang Zhong
Journal:  J Interv Cardiol       Date:  2021-06-02       Impact factor: 2.279

10.  Comparison of high-power short-duration and low-power long-duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta-analysis.

Authors:  Chao-Feng Chen; Jing Wu; Chao-Lun Jin; Mei-Jun Liu; Yi-Zhou Xu
Journal:  Clin Cardiol       Date:  2020-10-27       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.